India · Delayed Price · Currency is INR Anuh Pharma Statistics
Total Valuation
Anuh Pharma has a market cap or net worth of INR 7.60 billion. The enterprise value is 7.07 billion.
| Market Cap | 7.60B |
| Enterprise Value | 7.07B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Aug 5, 2026 |
Share Statistics
Anuh Pharma has 100.22 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 100.22M |
| Shares Outstanding | 100.22M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 72.67% |
| Owned by Institutions (%) | 0.00% |
| Float | 27.07M |
Valuation Ratios
The trailing PE ratio is 17.22.
| PE Ratio | 17.22 |
| Forward PE | n/a |
| PS Ratio | 0.98 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.01 |
| EV / Sales | 0.91 |
| EV / EBITDA | 9.50 |
| EV / EBIT | 11.31 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | -0.01 |
| Interest Coverage | 236.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.33% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.97% |
| Revenue Per Employee | 24.12M |
| Profits Per Employee | 1.37M |
| Employee Count | 323 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Anuh Pharma has paid 160.27 million in taxes.
| Income Tax | 160.27M |
| Effective Tax Rate | 26.62% |
Stock Price Statistics
The stock price has decreased by -14.10% in the last 52 weeks. The beta is 0.49, so Anuh Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -14.10% |
| 50-Day Moving Average | 78.95 |
| 200-Day Moving Average | 78.75 |
| Relative Strength Index (RSI) | 36.46 |
| Average Volume (20 Days) | 5,406 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anuh Pharma had revenue of INR 7.79 billion and earned 441.70 million in profits. Earnings per share was 4.40.
| Revenue | 7.79B |
| Gross Profit | 1.75B |
| Operating Income | 625.39M |
| Pretax Income | 601.96M |
| Net Income | 441.70M |
| EBITDA | 740.56M |
| EBIT | 625.39M |
| Earnings Per Share (EPS) | 4.40 |
Balance Sheet
The company has 529.19 million in cash and 583,000 in debt, with a net cash position of 528.61 million or 5.27 per share.
| Cash & Cash Equivalents | 529.19M |
| Total Debt | 583,000 |
| Net Cash | 528.61M |
| Net Cash Per Share | 5.27 |
| Equity (Book Value) | 3.52B |
| Book Value Per Share | 35.14 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -30.12 million and capital expenditures -78.69 million, giving a free cash flow of -108.80 million.
| Operating Cash Flow | -30.12M |
| Capital Expenditures | -78.69M |
| Depreciation & Amortization | 115.17M |
| Net Borrowing | -108.52M |
| Free Cash Flow | -108.80M |
| FCF Per Share | -1.09 |
Margins
Gross margin is 22.43%, with operating and profit margins of 8.03% and 5.67%.
| Gross Margin | 22.43% |
| Operating Margin | 8.03% |
| Pretax Margin | 7.73% |
| Profit Margin | 5.67% |
| EBITDA Margin | 9.51% |
| EBIT Margin | 8.03% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.97%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 1.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | 1.90% |
| Earnings Yield | 5.81% |
| FCF Yield | -1.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 15, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |